Diaceutics PLC (AIM:DXRX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
150.50
0.00 (0.00%)
At close: Feb 27, 2026
3.44%
Market Cap 127.80M
Revenue (ttm) 34.40M
Net Income (ttm) -1.52M
Shares Out 84.92M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE 242.74
Dividend n/a
Ex-Dividend Date n/a
Volume 45,018
Average Volume 129,298
Open 150.50
Previous Close 150.50
Day's Range 149.00 - 152.00
52-Week Range 106.00 - 176.25
Beta 1.08
RSI 34.20
Earnings Date May 27, 2026

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using... [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 2005
Employees 213
Stock Exchange London Stock Exchange AIM
Ticker Symbol DXRX
Full Company Profile

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.

Financial Statements

News

There is no news available yet.